Dr. Melinda Gail Abernethy, MD

Dr. Abernethy practices at Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group.

Dr. Abernethy's NPI, 1427254226, was assigned on June 27, 2007. Dr. Abernethy graduated from University of North Carolina School of Medicine in 2007. Dr. Abernethy holds Michigan license 4301089871.

Dr. Abernethy's primary practice is Bronson Methodist Hospital, at 601 John Street, Kalamazoo, MI 49007 in Kalamazoo County. The practice phone is (269) 341-6000.

Dr. Abernethy's primary practice is Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group. Dr. Abernethy is also affiliated with Bronson Battle Creek Hospital. The medical group on file is Bronson Medical Group. Dmand AI also links Dr. Abernethy to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abernethy practices, 5 sites in all. Vendor and product names are available with a free account.

Reproductive endocrinology is Dr. Abernethy's primary specialty in the NPI Registry, under taxonomy code 207VE0102X. Dr. Abernethy is board certified in female pelvic medicine and reconstructive surgery by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Abernethy's licenses on file in 3 states: Michigan, Maryland and Illinois.

Dmand AI lists bladder disease, hysterectomy, menopause, pelvic prolapse, UTI, vaginal infection, vaginal prolapse repair and vaginal repair among the conditions Dr. Abernethy treats.

CMS data shows 433 Medicare services from Dr. Abernethy across 14 procedure codes in 2024, for 195 Medicare patients. Medicare paid $54,454 for them.

CMS counts 195 Medicare patients who saw Dr. Abernethy in 2024. The largest group is 65 to 74, with 106 patients. 69% of them have high cholesterol, and 58% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abernethy's median patient age at 70, with 96% women.

In 2024, Dr. Abernethy wrote 1,170 Medicare Part D claims for 358 patients. 74% of them were for generic drugs. CMS names the drug for 1,064 of them, across 20 drugs with 11 or more claims each, at $156,807 in total drug cost. In 2023, CMS named 843 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Abernethy for performance year 2024, reported as part of a group. Dr. Abernethy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abernethy as offering telehealth. CMS counts 13 procedures of removal of the uterus by Dr. Abernethy, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Abernethy, published from 2014 to 2018. 2017 was the busiest year, with 3. The most frequent topics are Laparoscopy, Pelvic Organ Prolapse and Gynecologic Surgical Procedures. Dr. Abernethy has published most often in Female Pelvic Med Reconstr Surg. Dr. Abernethy's most frequent co-authors are Kimberly S. Kenton, MD, Margaret G. Mueller, MD and Christina E. Lewicky-Gaupp, MD.

Dmand AI links Dr. Abernethy to 1 clinical trial. Conditions studied include Pain, Postoperative and Postoperative Complications.

CMS Open Payments shows 25 general payments to Dr. Abernethy from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $395.

Dr. Abernethy graduated from University of North Carolina School of Medicine in 2007. Dr. Abernethy is a member of American College of Obstetricians and Gynecologists.

Dr. Abernethy is in network with 18 carriers, including Aetna, Health Alliance Plan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.